Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;55(6):105969.
doi: 10.1016/j.ijantimicag.2020.105969. Epub 2020 Apr 9.

Drug repositioning is an alternative for the treatment of coronavirus COVID-19

Marissa B Serafin  1 , Angelita Bottega  1 , Vitória S Foletto  1 , Taciéli F da Rosa  1 , Andreas Hörner  2 , Rosmari Hörner  3
Affiliations
Review

Drug repositioning is an alternative for the treatment of coronavirus COVID-19

Marissa B Serafin et al. Int J Antimicrob Agents. 2020 Jun.

Abstract

Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.

Keywords: COVID-19; Repositioning; SARS-CoV-2.

PubMed Disclaimer

References

    1. World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19. 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re... (March 11, 2020), Accessed 17 March 2020.
    1. Wang L.S., Wang Y.R., Ye D.W., Liu Q.Q. A review of the 2019 novel coronavirus (COVID-19) based on current evidence. Int J Antimicrob Agents. 2020 - PMC - PubMed
    1. Baron S.A., Devaux C., Colson P., Raoult D., Rolain M.J. Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19? Int J Antimicrob Agents. 2020 doi: 10.1016/j.ijantimicag.2020.105944. - DOI - PMC - PubMed
    1. Serafin M.B., Hörner R. Drug repositioning, a new alternative in infectious diseases. Braz J Infec Dis. 2018;22(3):252–256. doi: 10.1016/j.bjid.2018.05.007. - DOI - PMC - PubMed
    1. Foletto V.S., Serafin M.B., Bottega A., da Rosa T.F., de S., Machado C., Coelho S.S. Repositioning of fluoxetine and paroxetine: study of potential antibacterial activity and its combination with ciprofloxacin. Medicinal Chemistry Research. 2020;29:556. –53.

MeSH terms